PE ratio relative to earnings growth — is the valuation justified?
| Symbol | Company | PEG | P/E | Growth | vs XRAY |
|---|---|---|---|---|---|
| RMD | ResMed Inc. | 0.81 | 21.2 | 26.1% | — |
| ALC | Alcon Inc. | 1.34 | 55.8 | 41.7% | — |
| MMSI | Merit Medical Systems, Inc. | 1.42 | 26.1 | 18.3% | — |
| BDX | Becton, Dickinson and Company | 3.37 | 54.8 | 16.3% | — |
| HAE | Haemonetics Corporation | 5.04 | 27.6 | 5.5% | — |